Mostrando 3 resultados de: 3
Subtipo de publicación
Article(3)
Área temáticas
Enfermedades(2)
Farmacología y terapéutica(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Medicina y salud(1)
Salud y seguridad personal(1)
Origen
scopus(3)
Adjuvant Cyclophosphamide, Methotrexate, and Fluorouracil Versus Fluorouracil, Epirubicin, and Cyclophosphamide Chemotherapy in Premenopausal Women with Axillary Node-Positive Operable Breast Cancer: Results of a Randomized Trial
ArticleAbstract: Purpose: To determine whether a combination chemotherapy regimen that contains epirubicin (fluorouraPalabras claves:Autores:Aapro M., Amadori D., Bliss J.M., Chilvers C.E.D., Coombes G., Coombes R.C., Espié M., Faustino R. Pérez-López, Gambrosier P., Marty M., McArdle C., Morvan F., Pinto Ferreira E., Richards M., Vassilopoulos P., Villar-Grimalt A., Wils J.A., Woods E.M.Fuentes:scopusEpirubicin dose and sequential hormonal therapy - Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer
ArticleAbstract: Background The hormonal manipulation 5-Fluoro-uracil Epirubicin Cyclophosphamide (HMFEC) trial was dPalabras claves:adjuvant, Breast Cancer, chemotherapy, Clinical trial, Disease outcome, Hormone manipulationAutores:Bliss J.M., Coombes R.C., Faustino R. Pérez-López, Kilburn L.S., Olmos T., Palmieri C., Stebbing J., Tubiana-Mathieu N., Van Bochove A.Fuentes:scopusEpirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group
ArticleAbstract: Purpose: To assess whether the addition of epirubicin (EPI) therapy to prolonged treatment with tamoPalabras claves:Autores:Bliss J.M., Coombes G., Coombes R.C., Faustino R. Pérez-López, Fontaine C., Marty M., Morvan F., Olmos T., Vassilopoulos P., Wils J.A., Woods E.M.Fuentes:scopus